Thromb Haemost 1982; 48(03): 247-249
DOI: 10.1055/s-0038-1657271
Original Article
Schattauer GmbH Stuttgart

Plasma Fibrinopeptide A and Beta-Thromboglobulin in Major Bacterial Infections

H van Hulsteijn
The Thrombosis and Haemostasis Research Unit, University Hospital Leiden, Leiden, The Netherlands
,
W Fibbe
*   The Dept. of Infectious Diseases, University Hospital Leiden, Leiden, The Netherlands
,
R Bertina
The Thrombosis and Haemostasis Research Unit, University Hospital Leiden, Leiden, The Netherlands
,
E Briët
The Thrombosis and Haemostasis Research Unit, University Hospital Leiden, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 13 April 1982

Accepted 30 August 1982

Publication Date:
21 August 2018 (online)

Summary

The purpose of this study was to assess the usefulness of plasma fibrinopeptide A and beta-thromboglobulin concentrations for the diagnosis of acute venous thromboembolism in patients with a major bacterial infection. In 80 controls the mean plasma fibrinopeptide A concentration was 0.72 ± 0.47 (ng/ml ± SD) and the mean plasma beta-thromboglobulin concentration 28.2 ± 10.1 (ng/ml ± SD).

On admission the mean fibrinopeptide A concentration was significantly raised (5.42 ng/ml) in these patients and 17 of them had a raised fibrinopeptide A concentration. However, the mean beta-thromboglobulin concentration was not significantly different from that of the healthy individuals (35.4 ng/ml) and only three patients had an increased beta-thromboglobulin concentration.

Our data show that patients with major bacterial infections tend to have increased fibrinopeptide A and normal beta-thromboglobulin concentrations. Consequently, the measuring of plasma fibrinopeptide A concentration is useless for the diagnosis of acute venous thromboembolism in these patients. However, the determination of plasma beta-thromboglobulin concentration can still be used for this purpose, since a normal beta-thrombo-globulin concentration excludes the presence of acute venous thrombosis.

 
  • References

  • 1 Corrigan JJ, Ray WL, May N. Changes in the blood coagulation system associated with septicemia. N Engl J Med 1968; 279: 851-856
  • 2 Zimmerman TS, Fierer J, Rothberger H. Blood coagulation and the inflammatory response. Sem Hematol 1977; 14: 391-408
  • 3 Blombäck B. Fibrinogen to fibrin transformation. In: Seegers WH. (ed) Blood clotting enzymology. Academic Press; New York – London: 1967: 143-215
  • 4 Ludlam CA. Evidence for the platelet specificity of β-thromboglobulin and studies on its plasma concentration in healthy individuals. Br J Haematol 1979; 41: 271-278
  • 5 Ludlam CA, Bolton AE, Moore S, Cash JD. New rapid method for diagnosis of deep venous thrombosis. Lancet 1975; 2: 259-260
  • 6 Smith RC, Duncanson J, Ruckley CV. et al Beta-thromboglobulin and deep vein thrombosis. Thromb Haemostas 1978; 39: 338-345
  • 7 Yudelman IM, Nossel HL, Kaplan KL, Hirsh J. Plasma fibrinopeptide A levels in symptomatic venous thromboembolism. Blood 1978; 51: 1189-1195
  • 8 Peuscher FW, van Aken WG, Flier OThN, Stoepman-van Dalen EA, Cremer-Goote ThM, van Mourik JA. Effect of anticoagulant treatment measured by fibrinopeptide A (FPA) in patients with venous thromboembolism. Thromb Res 1980; 18: 33-43
  • 9 Hulsteijn H van, Briët E, Koch C, Hermans J, Bertina R. Diagnostic value of fibrinopeptide A and beta-thromboglobulin in acute deep venous thrombosis and pulmonary embolism. Acta Med Scand 1982; 211: 323-330
  • 10 Nossel HL, Yudelman I, Canfield RE. et al Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43-53
  • 11 Nossel HL, Ti M, Kaplan KL, Spanondis K, Soland T, Butler jr VP. The generation of fibrinopeptide A in clinical blood samples. Evidence for thrombin activity. J Clin Invest 1976; 58: 1136-1144
  • 12 Neame PB, Kelton JG, Walker IR, Stewart IO, Nossel HL, Hirsh J. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 1980; 56: 88-92
  • 13 Han P, Turpie AGG, Genton E. Plasma β-thromboglobulin: differentiation between intravascular and extravascular platelet destruction. Blood 1979; 54: 1192-1196
  • 14 Parbtani A, Frampton G, Cameron JS. Measurement of platelet release substances in glomerulonephritis: a comparison of beta-thromboglobulin (β-TG), platelet factor 4 (PF 4) and serotonin assays. Thromb Res 1980; 19: 177-189
  • 15 van Hulsteijn H, Briët E, Bertina R. Simplified procedure for the assay of fibrinopeptide A in plasma. Thromb Res 1981; 21: 207-213